Nature Communications (Nov 2019)
Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer
Abstract
Imaging metastatic disease burden in lymph nodes is important for surgical decision making. Here, the authors use an antibody-dye conjugate to distinguish between metastatic and benign lymph nodes in head and neck cancer.